🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to see if kidney function can be improved duri...
Status
Completed
Location
Ilene Blechman-Krom
Start Date
2000-04
Trial ID
NCT00007787
Treatments Being Tested
RATIONALE: - Relapsed or refractory Neuroblastoma (NBL) carries a very poor...
Status
Withdrawn
Location
Children's Memorial Hospital
Start Date
2008-09
Trial ID
NCT00874315
This phase II trial investigates side effects and how well donor stem cell ...
Status
Terminated
Location
M D Anderson Cancer Center
Start Date
2020-08-19
Trial ID
NCT04530487
The primary purpose is to provide access for patients who have immunodefici...
Status
Completed
Location
Multiple Locations
Start Date
2014-08
Trial ID
NCT02274662
The purpose of this research study is to compare the effects of the two mos...
Status
Completed
Location
Wake Forest University Baptist Medical Center
Start Date
2005-02
Trial ID
NCT00331162
Treatments Being Tested
This is a single-arm study to investigate 1-year treatment related mortalit...
Status
Recruiting
Location
Memorial Sloan Kettering Cancer Center
Start Date
2020-11-20
Trial ID
NCT04644016
Treatments Being Tested
To assess the outcomes of NRM when administering pharmacologic pretransplan...
Status
Withdrawn
Location
M D Anderson Cancer Center
Start Date
2022-03-02
Trial ID
NCT05293509
This is a Phase II, single arm, multi-center trial. It is designed to estim...
Status
Completed
Location
Children's Hospital of Oakland
Start Date
2012-03
Trial ID
NCT01565616
Treatments Being Tested
To assess the tolerability of the costimulation blocking agent abatacept (C...
Status
Completed
Location
Children's National Medical Center
Start Date
2016-07
Trial ID
NCT02867800
This is a 2-year, randomized, multicenter, open-label, 2-arm study evaluati...
Status
Completed
Location
Novartis Investigative Site
Start Date
2013-12-03
Trial ID
NCT01950819
Treatments Being Tested